Cargando…
The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking
BACKGROUND: Interstitial lung disease (ILD) is associated with substantial morbidity and mortality, which is one of the key systematic manifestations of connective tissue disease (CTD). Tripterygium wilfordii, known as Leigongteng in Chinese, has been applied to treat connective tissue disease-relat...
Autores principales: | Zhu, Wen, Li, Yehui, Zhao, Junjie, Wang, Yifan, Li, Yixi, Wang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843192/ https://www.ncbi.nlm.nih.gov/pubmed/35132912 http://dx.doi.org/10.1080/07853890.2022.2034931 |
Ejemplares similares
-
Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease
por: Jang, Hye Jin, et al.
Publicado: (2023) -
Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities
por: Zhang, Yun, et al.
Publicado: (2023) -
Resting pulmonary function and artery pressure and cardiopulmonary exercise testing in chronic heart failure patients in Taiwan − a prospective observational cross-sectional study comparing healthy subjects and interstitial lung disease patients
por: Chuang, Ming-Lung, et al.
Publicado: (2023) -
HRCT in smoking-related interstitial lung diseases: a kaleidoscopic overlap of patterns
por: Rea, Gaetano, et al.
Publicado: (2016) -
Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
por: Dotan, Yaniv, et al.
Publicado: (2020)